5 Federal Requirements for Pharmacy Practice

The federal baseline and state rules

Federal pharmacy requirements establish a baseline for lawful dispensing, prescription-container labeling, certain patient-information duties, Medicaid drug review and counseling, and protection of health information. State pharmacy laws commonly add more detailed requirements, especially for prescription validity, counseling, labeling, record retention, and pharmacist judgment; they may also be stricter. Pharmacists must follow the rules that apply to the state and dispensing setting as well as federal law.

Prescription processing

Under the Federal Food, Drug, and Cosmetic Act, a Prescription-only drug generally may be dispensed only under one of these forms of authority:

• A written prescription from a practitioner legally authorized to prescribe the drug.

• An oral prescription that the pharmacist promptly reduces to writing and files.

• A refill authorized by the prescriber.

Dispensing contrary to these requirements is treated as misbranding.

In practice, prescription processing involves checking that the prescription is legally authorized and complete, resolving material ambiguities with the prescriber, and evaluating whether the drug and directions can be dispensed safely. If directions conflict with the quantity or appear clinically inappropriate, the pharmacist should resolve the concern before dispensing and document relevant communications as required by applicable law and policy. This workflow is not a single, comprehensive federal checklist that applies identically to every prescription and payer.

Prescription-container labeling

Federal law specifies information that must appear on a prescription drug for the statutory labeling exemption to apply:

• The dispenser’s name and address.

• The prescription serial number and the date of the prescription or its filling.

• The prescriber’s name.

• The patient’s name, if stated on the prescription.

• The directions and cautionary statements contained in the prescription.

The prescription drug must also bear “Rx only” before dispensing. State law may require additional information or particular formatting.

The pharmacy’s patient-container label is distinct from the manufacturer’s product labeling; FDA regulations separately address labeling of prescription-drug products.

Medication Guide distribution

Some prescription drugs require an FDA-approved Medication Guide. When dispensing a drug subject to this requirement, the authorized dispenser generally must give the Guide to the patient or the patient’s agent unless a regulatory exemption applies.

Medicaid drug review and counseling

Federal counseling and prospective drug-review requirements are especially explicit for Medicaid-covered outpatient prescriptions. State Medicaid plans must provide for review of drug therapy before a prescription is filled or delivered. The review screens for potential problems such as therapeutic duplication, drug–disease contraindications, drug interactions, incorrect dosage or duration, allergies, and clinical abuse or misuse.

State plans must also establish counseling standards and require an offer to counsel each beneficiary or caregiver who presents a prescription. The offer is generally made in person when practicable or through a toll-free telephone service where required. A beneficiary or caregiver may refuse counseling.

Counseling standards must address, as professionally significant:

• The medication’s name and description.

• Dosage form, dose, route, and duration.

• Special directions and precautions.

• Important adverse effects and interactions.

• Self-monitoring and storage.

• Refills and what to do about a missed dose.

The same regulation requires reasonable efforts to obtain and maintain Medicaid patient profiles, including relevant history, allergies, medications, and pharmacist comments. State rules determine implementation details, including which counseling offers or refusals must be documented.

These Medicaid requirements are not a universal federal counseling mandate for every prescription and every patient. Other federal program rules and state law may impose additional duties. Pharmacists should also follow applicable professional standards and pharmacy procedures when a clinical concern arises, even when a particular federal rule does not prescribe a detailed process.

Documentation, privacy, and retention

Documenting prescription processing, interventions, prescriber contacts, counseling, and patient refusals supports safe care. Documentation may be required by state law, Medicaid rules, payer conditions, or pharmacy policy. For Medicaid prospective drug review, federal regulations direct states to provide pharmacies guidance on documentation and require state counseling standards to specify documentation of a refusal of an offer to counsel.

Pharmacies that are HIPAA covered entities must protect patients’ protected health information using appropriate administrative, technical, and physical safeguards. HIPAA does not generally set a retention period for all medical or prescription records. It does require covered entities to retain certain HIPAA-required documentation, such as relevant policies, procedures, and required records, for six years from creation or from the date it was last in effect, whichever is later. State record-retention laws and other program requirements may require longer retention of pharmacy records.